NCT03493178View on ClinicalTrials.gov

Glutathione in Mild Cognitive Impairment

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

May 30, 2025

Study Completion Date

December 31, 2025

Conditions
Mild Cognitive Impairment
Interventions
DIETARY_SUPPLEMENT

Glycine

Dietary Supplement: glycine will be supplemented in the active arm for 12-weeks

DIETARY_SUPPLEMENT

N-acetylcysteine (NAC)

Dietary Supplement: NAC will be supplemented in the active arm for 12-weeks

DIETARY_SUPPLEMENT

Alanine

Dietary Supplement: Alanine will be supplemented in the placebo arm for 12-weeks

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

The Methodist Hospital Research Institute

OTHER

lead

Baylor College of Medicine

OTHER